Imatinib Price Online

[thomassins]

Imatinib, also known as Gleevec, is a targeted cancer drug that was first approved by the FDA in 2001. It is used to treat chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). The Imatinib price of a 30-day supply  is $146,560, making it one of the most expensive cancer drugs on the market.

Despite high Gleevec cost, Gleevec has been shown to be an effective treatment for CML and GIST. In clinical trials, patients treated with Gleevec had a significantly higher rate of survival than those who did not receive the drug. In addition, Gleevec has been shown to be effective in treating patients who have relapsed after other treatment options have failed.

The high Imatinib price has created a financial burden for many patients. In order to make the drug more affordable, patients can ask their doctor about generic options, which are available at a fraction of the cost of the brand-name drug. In addition, financial assistance programs are available to help patients cover the Imatinib price.

Despite high Imatinib price, Gleevec is a life-saving cancer drug that has helped thousands of patients.